Fibroid surgery Follow-Up drug trial pulled before it began
NCT ID NCT05538689
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aimed to see if taking Myfembree (a combination pill) daily after fibroid removal surgery could delay the return of fibroids and improve quality of life. It was designed for premenopausal women with uterine fibroids who had surgery. However, the trial was withdrawn before any participants were enrolled, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Myfembree (relugolix, estradiol, norethindrone acetate)
What this could lead to
If it had worked, this could point toward a way to delay fibroid regrowth and reduce the need for repeat surgery after myomectomy.
What could go wrong
The trial was withdrawn before enrolling anyone, so no results are available. Even if conducted, it was a small early-phase study, and benefits may not have been confirmed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METRORRHAGIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago DCAM
Chicago, Illinois, 60637, United States
-
University of Chicago Flossmoor
Flossmoor, Illinois, 60422, United States
-
University of Chicago Orland Park
Orland Park, Illinois, 60462, United States
-
University of Chicago River East
Chicago, Illinois, 60611, United States
-
University of Chicago Schererville
Schererville, Indiana, 46375, United States
-
University of Chicago South Loop
Chicago, Illinois, 60607, United States